MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$22,704K
(7.79%↑ Y/Y)
Other income
(expense), net
$680K
(23.86%↑ Y/Y)
Clinical Trial Revenue
$954K
(-31.95%↓ Y/Y)
Contract Manufacturing
Revenue
$222K
(-54.41%↓ Y/Y)
Contract Manufacturing
Lease Revenue
$23K
(-95.43%↓ Y/Y)
Net loss
-$22,704K
(-42.14%↓ Y/Y)
Total other income
(expenses), net
$583K
(6.19%↑ Y/Y)
Total revenues
$1,199K
(-49.87%↓ Y/Y)
Loss on disposal of
assets
-$97K
Loss from operations
-$23,287K
(-40.95%↓ Y/Y)
Gross profit
$803K
(-57.38%↓ Y/Y)
Cost of revenues
$396K
(-22.05%↓ Y/Y)
Total operating
expenses
$24,090K
(30.88%↑ Y/Y)
General and
administrative
$12,049K
(17.33%↑ Y/Y)
Research and development
$12,041K
(47.98%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Longeveron Inc. (LGVN)
Longeveron Inc. (LGVN)